Inventor and Patent Holder of the GENOS Method, Claudia Klein

Epigenetics, Microbiology, Biochemistry, Toxicology & Homotoxicology, Biophysics & Biological Cellular Regulation, Space Medicine & Tibetan Medicine, Bionics & Non-Violent Communication, Leadership in Conscious Business - developer of the "Bird flock prin

Claudia Klein is the inventor and patent holder of the GENOS method, a leader in the field of regenerative medicine and causal diagnostics. With an academic background in Pharmaceutical Chemistry, Pharmacology, Toxicology, and Causal Diagnostics, she has accumulated extensive experience in innovative research and applications in cell biology and epigenetics.

Areas of Expertise:

Epigenetics
Microbiology
Biochemistry
Toxicology & Homotoxicology
Biophysics & Cellular Biological Regulation
Space Medicine & Tibetan Medicine
Bionics & Non-Violent Communication
Leadership in Conscious Business - developer of the "Bird flock principle"

Main Research Areas:

Theoretical Biophysics
Cellular Epigenetics

Claudia Klein is a causal diagnostician with over 20 years of experience in holistic and regenerative medicine. Her in-depth knowledge in the fields of toxicology, homotoxicology, epigenetics and regulation of cellular function make her a sought-after expert, collaborating with doctors and therapists all over Europe.

Major Achievements:

GENOS Method - Claudia Klein discovered the GENOS cellular mechanism, which has been patented in both the USA and Europe. It is the basis of the personalized GENOS INSIDE medicines and GENOS infusions.

YENO QUANTUM ONE - she is also the developer of the YENO QUANTUM ONE technology used in production.

Contributions in Oncology:

Her innovative research in the field of cancer therapy was published worldwide in March 2022. Based on this, she developed the REVERSE therapy, which offers a personalized approach to treating 12 types of cancer, using epigenetic medicines as an adjuvant therapy for doctors, clinics and patients.

Healthy Aging:

Another innovative product developed by Claudia Klein is FIBROCELL, a market leader in cellular rejuvenation, representing another significant achievement in the anti-aging industry.

Membership in professional organizations:

• Member of ISCMR (International Society for Complementary & Integrative Research)
• Honorary member of WAoFP (Worldwide Association of Female Professionals)

With a remarkable track record in research, education and innovation, Claudia Klein continues to bring major changes to modern medicine, through epigenetic approaches and personalized solutions for cellular health and regeneration.